Fonar Corp. logo

Fonar Corp.

FONR | NASDAQ
Chart Builder DCF Calculator
$19.09
$0 (0.00%)
Jun 5, 2026, 4:00 PM ET · Market open

Company Profile

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 39 MRI scanning facilities, including 25 facilities located in New York and 14 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.

Key Executives

Name Position
Timothy R. Damadian Chairman, President, Chief Executive Officer & Treasurer
Luciano Bonanni Chief Operating Officer, Executive Vice President & Acting Principal Financial Officer
Daniel Culver Director of Communications
John Collins General Counsel & Acting Secretary

Latest SEC Filings

Date Type Title
Jun 04, 2026 4 Filing
Jun 03, 2026 SC 13D/A [Amend] Filing
Jun 03, 2026 25-NSE Filing
May 29, 2026 4 Filing
May 29, 2026 8-K Current Report
May 27, 2026 4 Filing
May 26, 2026 3 Filing
May 21, 2026 DEFA14A Filing
May 21, 2026 8-K Current Report
May 14, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
View All SEC Filings
Fonar Corp.
Fonar Corp. logo
Country United States
IPO Date Oct 28, 1981
Industry Medical - Devices
Sector Healthcare
Employees 520
CEO Timothy R. Damadian

Contact Details

110 Marcus Drive Melville, New York 11747 United States

Stock Details

Ticker Symbol FONR
Exchange NASDAQ
Fiscal Year July - June
Reporting Currency USD
CIK Code 0000355019
CUSIP Number 344437405
ISIN Number US3444374058
SIC Code 3845

© 2026 bestshares.com. All rights reserved.